nodes	percent_of_prediction	percent_of_DWPC	metapath
Ranitidine—CYP1A2—Imiquimod—skin cancer	0.125	0.153	CbGbCtD
Ranitidine—CYP2C19—Vismodegib—skin cancer	0.0939	0.115	CbGbCtD
Ranitidine—ABCB1—Vismodegib—skin cancer	0.0757	0.0925	CbGbCtD
Ranitidine—CYP1A2—Vemurafenib—skin cancer	0.0685	0.0836	CbGbCtD
Ranitidine—CYP3A4—Imiquimod—skin cancer	0.0655	0.0799	CbGbCtD
Ranitidine—CYP3A4—Temozolomide—skin cancer	0.0655	0.0799	CbGbCtD
Ranitidine—CYP2D6—Vemurafenib—skin cancer	0.0564	0.0689	CbGbCtD
Ranitidine—CYP1A2—Dacarbazine—skin cancer	0.0525	0.0641	CbGbCtD
Ranitidine—CYP3A4—Vismodegib—skin cancer	0.0454	0.0554	CbGbCtD
Ranitidine—ABCB1—Dactinomycin—skin cancer	0.0398	0.0486	CbGbCtD
Ranitidine—CYP3A4—Vemurafenib—skin cancer	0.0359	0.0438	CbGbCtD
Ranitidine—CYP3A5—Docetaxel—skin cancer	0.0316	0.0385	CbGbCtD
Ranitidine—CYP1A2—Fluorouracil—skin cancer	0.0308	0.0376	CbGbCtD
Ranitidine—ABCB1—Docetaxel—skin cancer	0.0205	0.0251	CbGbCtD
Ranitidine—CYP3A4—Docetaxel—skin cancer	0.0123	0.015	CbGbCtD
Ranitidine—Abdominal pain—Vismodegib—skin cancer	0.0011	0.0061	CcSEcCtD
Ranitidine—Hepatic failure—Dactinomycin—skin cancer	0.0011	0.0061	CcSEcCtD
Ranitidine—Alopecia—Vemurafenib—skin cancer	0.00107	0.00593	CcSEcCtD
Ranitidine—Erythema—Vemurafenib—skin cancer	0.00106	0.00584	CcSEcCtD
Ranitidine—Hepatic failure—Temozolomide—skin cancer	0.000998	0.00551	CcSEcCtD
Ranitidine—Pruritus—Vismodegib—skin cancer	0.000987	0.00546	CcSEcCtD
Ranitidine—Erythema multiforme—Imiquimod—skin cancer	0.000979	0.00541	CcSEcCtD
Ranitidine—Diarrhoea—Vismodegib—skin cancer	0.000955	0.00528	CcSEcCtD
Ranitidine—Photosensitivity—Fluorouracil—skin cancer	0.000941	0.0052	CcSEcCtD
Ranitidine—Arrhythmia—Imiquimod—skin cancer	0.000925	0.00511	CcSEcCtD
Ranitidine—Alopecia—Imiquimod—skin cancer	0.000915	0.00506	CcSEcCtD
Ranitidine—Bronchospasm—Bleomycin—skin cancer	0.000904	0.00499	CcSEcCtD
Ranitidine—Erythema—Imiquimod—skin cancer	0.000901	0.00498	CcSEcCtD
Ranitidine—Arthralgia—Vemurafenib—skin cancer	0.000899	0.00497	CcSEcCtD
Ranitidine—Myalgia—Vemurafenib—skin cancer	0.000899	0.00497	CcSEcCtD
Ranitidine—Vomiting—Vismodegib—skin cancer	0.000887	0.0049	CcSEcCtD
Ranitidine—Rash—Vismodegib—skin cancer	0.00088	0.00486	CcSEcCtD
Ranitidine—Dermatitis—Vismodegib—skin cancer	0.000879	0.00486	CcSEcCtD
Ranitidine—Pancytopenia—Bleomycin—skin cancer	0.000872	0.00482	CcSEcCtD
Ranitidine—Anaphylactic shock—Vemurafenib—skin cancer	0.000862	0.00477	CcSEcCtD
Ranitidine—Dysphagia—Dactinomycin—skin cancer	0.000857	0.00474	CcSEcCtD
Ranitidine—Ill-defined disorder—Imiquimod—skin cancer	0.000836	0.00462	CcSEcCtD
Ranitidine—Weight decreased—Bleomycin—skin cancer	0.000831	0.00459	CcSEcCtD
Ranitidine—Nausea—Vismodegib—skin cancer	0.000829	0.00458	CcSEcCtD
Ranitidine—Agitation—Imiquimod—skin cancer	0.000828	0.00458	CcSEcCtD
Ranitidine—Pneumonia—Bleomycin—skin cancer	0.000824	0.00455	CcSEcCtD
Ranitidine—Angioedema—Imiquimod—skin cancer	0.000823	0.00455	CcSEcCtD
Ranitidine—Hepatocellular injury—Docetaxel—skin cancer	0.000821	0.00454	CcSEcCtD
Ranitidine—Pancytopenia—Dactinomycin—skin cancer	0.000814	0.0045	CcSEcCtD
Ranitidine—Malaise—Imiquimod—skin cancer	0.000812	0.00449	CcSEcCtD
Ranitidine—Breast disorder—Temozolomide—skin cancer	0.00081	0.00448	CcSEcCtD
Ranitidine—Hypotension—Vemurafenib—skin cancer	0.000806	0.00445	CcSEcCtD
Ranitidine—Neutropenia—Dactinomycin—skin cancer	0.000801	0.00443	CcSEcCtD
Ranitidine—Alanine aminotransferase increased—Temozolomide—skin cancer	0.000791	0.00437	CcSEcCtD
Ranitidine—Musculoskeletal discomfort—Vemurafenib—skin cancer	0.000785	0.00434	CcSEcCtD
Ranitidine—Cardiac arrest—Fluorouracil—skin cancer	0.000785	0.00434	CcSEcCtD
Ranitidine—Dysphagia—Temozolomide—skin cancer	0.000775	0.00428	CcSEcCtD
Ranitidine—Pneumonia—Dactinomycin—skin cancer	0.000768	0.00425	CcSEcCtD
Ranitidine—Arthralgia—Imiquimod—skin cancer	0.000767	0.00424	CcSEcCtD
Ranitidine—Chest pain—Imiquimod—skin cancer	0.000767	0.00424	CcSEcCtD
Ranitidine—Myalgia—Imiquimod—skin cancer	0.000767	0.00424	CcSEcCtD
Ranitidine—Discomfort—Imiquimod—skin cancer	0.000758	0.00419	CcSEcCtD
Ranitidine—Constipation—Vemurafenib—skin cancer	0.000737	0.00408	CcSEcCtD
Ranitidine—Pancytopenia—Temozolomide—skin cancer	0.000736	0.00407	CcSEcCtD
Ranitidine—Lightheadedness—Docetaxel—skin cancer	0.000735	0.00406	CcSEcCtD
Ranitidine—Neutropenia—Temozolomide—skin cancer	0.000725	0.00401	CcSEcCtD
Ranitidine—Tachycardia—Imiquimod—skin cancer	0.000718	0.00397	CcSEcCtD
Ranitidine—Dysphagia—Fluorouracil—skin cancer	0.000714	0.00395	CcSEcCtD
Ranitidine—Erectile dysfunction—Temozolomide—skin cancer	0.000714	0.00394	CcSEcCtD
Ranitidine—Agranulocytosis—Dactinomycin—skin cancer	0.000713	0.00394	CcSEcCtD
Ranitidine—Hyperhidrosis—Imiquimod—skin cancer	0.000711	0.00393	CcSEcCtD
Ranitidine—Photosensitivity reaction—Temozolomide—skin cancer	0.000707	0.00391	CcSEcCtD
Ranitidine—Eosinophilia—Fluorouracil—skin cancer	0.000707	0.00391	CcSEcCtD
Ranitidine—Weight decreased—Temozolomide—skin cancer	0.000701	0.00388	CcSEcCtD
Ranitidine—Angina pectoris—Fluorouracil—skin cancer	0.000695	0.00384	CcSEcCtD
Ranitidine—Pneumonia—Temozolomide—skin cancer	0.000695	0.00384	CcSEcCtD
Ranitidine—Hepatitis—Dactinomycin—skin cancer	0.000686	0.00379	CcSEcCtD
Ranitidine—Body temperature increased—Vemurafenib—skin cancer	0.000682	0.00377	CcSEcCtD
Ranitidine—Pancytopenia—Fluorouracil—skin cancer	0.000678	0.00375	CcSEcCtD
Ranitidine—Musculoskeletal discomfort—Imiquimod—skin cancer	0.00067	0.0037	CcSEcCtD
Ranitidine—Insomnia—Imiquimod—skin cancer	0.000665	0.00368	CcSEcCtD
Ranitidine—Hepatic failure—Docetaxel—skin cancer	0.000663	0.00367	CcSEcCtD
Ranitidine—Dyspnoea—Imiquimod—skin cancer	0.000656	0.00362	CcSEcCtD
Ranitidine—Somnolence—Imiquimod—skin cancer	0.000654	0.00361	CcSEcCtD
Ranitidine—Photosensitivity reaction—Fluorouracil—skin cancer	0.000652	0.0036	CcSEcCtD
Ranitidine—Alopecia—Bleomycin—skin cancer	0.00065	0.00359	CcSEcCtD
Ranitidine—Erythema multiforme—Dactinomycin—skin cancer	0.000648	0.00358	CcSEcCtD
Ranitidine—Pneumonia—Fluorouracil—skin cancer	0.00064	0.00354	CcSEcCtD
Ranitidine—Erythema—Bleomycin—skin cancer	0.00064	0.00354	CcSEcCtD
Ranitidine—Hypersensitivity—Vemurafenib—skin cancer	0.000635	0.00351	CcSEcCtD
Ranitidine—Pain—Imiquimod—skin cancer	0.000629	0.00348	CcSEcCtD
Ranitidine—Hepatitis—Temozolomide—skin cancer	0.00062	0.00343	CcSEcCtD
Ranitidine—Hallucination—Temozolomide—skin cancer	0.000617	0.00341	CcSEcCtD
Ranitidine—Pruritus—Vemurafenib—skin cancer	0.00061	0.00337	CcSEcCtD
Ranitidine—Alopecia—Dactinomycin—skin cancer	0.000606	0.00335	CcSEcCtD
Ranitidine—Feeling abnormal—Imiquimod—skin cancer	0.000606	0.00335	CcSEcCtD
Ranitidine—Erythema—Dactinomycin—skin cancer	0.000597	0.0033	CcSEcCtD
Ranitidine—Agranulocytosis—Fluorouracil—skin cancer	0.000594	0.00328	CcSEcCtD
Ranitidine—Ill-defined disorder—Bleomycin—skin cancer	0.000594	0.00328	CcSEcCtD
Ranitidine—Anaemia—Bleomycin—skin cancer	0.000592	0.00327	CcSEcCtD
Ranitidine—Diarrhoea—Vemurafenib—skin cancer	0.00059	0.00326	CcSEcCtD
Ranitidine—Erythema multiforme—Temozolomide—skin cancer	0.000586	0.00324	CcSEcCtD
Ranitidine—Urticaria—Imiquimod—skin cancer	0.000584	0.00323	CcSEcCtD
Ranitidine—Body temperature increased—Imiquimod—skin cancer	0.000581	0.00321	CcSEcCtD
Ranitidine—Abdominal pain—Imiquimod—skin cancer	0.000581	0.00321	CcSEcCtD
Ranitidine—Malaise—Bleomycin—skin cancer	0.000577	0.00319	CcSEcCtD
Ranitidine—Leukopenia—Bleomycin—skin cancer	0.000573	0.00317	CcSEcCtD
Ranitidine—Dizziness—Vemurafenib—skin cancer	0.00057	0.00315	CcSEcCtD
Ranitidine—Ill-defined disorder—Dactinomycin—skin cancer	0.000554	0.00306	CcSEcCtD
Ranitidine—Anaemia—Dactinomycin—skin cancer	0.000552	0.00305	CcSEcCtD
Ranitidine—Vomiting—Vemurafenib—skin cancer	0.000548	0.00303	CcSEcCtD
Ranitidine—Alopecia—Temozolomide—skin cancer	0.000548	0.00303	CcSEcCtD
Ranitidine—Chest pain—Bleomycin—skin cancer	0.000545	0.00301	CcSEcCtD
Ranitidine—Myalgia—Bleomycin—skin cancer	0.000545	0.00301	CcSEcCtD
Ranitidine—Abdominal pain upper—Docetaxel—skin cancer	0.000545	0.00301	CcSEcCtD
Ranitidine—Rash—Vemurafenib—skin cancer	0.000544	0.003	CcSEcCtD
Ranitidine—Dermatitis—Vemurafenib—skin cancer	0.000543	0.003	CcSEcCtD
Ranitidine—Hypersensitivity—Imiquimod—skin cancer	0.000542	0.00299	CcSEcCtD
Ranitidine—Headache—Vemurafenib—skin cancer	0.00054	0.00299	CcSEcCtD
Ranitidine—Erythema—Temozolomide—skin cancer	0.00054	0.00298	CcSEcCtD
Ranitidine—Breast disorder—Docetaxel—skin cancer	0.000539	0.00298	CcSEcCtD
Ranitidine—Discomfort—Bleomycin—skin cancer	0.000538	0.00298	CcSEcCtD
Ranitidine—Malaise—Dactinomycin—skin cancer	0.000538	0.00298	CcSEcCtD
Ranitidine—Leukopenia—Dactinomycin—skin cancer	0.000534	0.00295	CcSEcCtD
Ranitidine—Confusional state—Bleomycin—skin cancer	0.000527	0.00291	CcSEcCtD
Ranitidine—Alanine aminotransferase increased—Docetaxel—skin cancer	0.000526	0.00291	CcSEcCtD
Ranitidine—Anaphylactic shock—Bleomycin—skin cancer	0.000522	0.00289	CcSEcCtD
Ranitidine—Pruritus—Imiquimod—skin cancer	0.00052	0.00288	CcSEcCtD
Ranitidine—Dysphagia—Docetaxel—skin cancer	0.000515	0.00285	CcSEcCtD
Ranitidine—Nausea—Vemurafenib—skin cancer	0.000512	0.00283	CcSEcCtD
Ranitidine—Thrombocytopenia—Bleomycin—skin cancer	0.000511	0.00283	CcSEcCtD
Ranitidine—Arrhythmia—Fluorouracil—skin cancer	0.00051	0.00282	CcSEcCtD
Ranitidine—Vision blurred—Temozolomide—skin cancer	0.000509	0.00281	CcSEcCtD
Ranitidine—Myalgia—Dactinomycin—skin cancer	0.000508	0.00281	CcSEcCtD
Ranitidine—Bronchospasm—Docetaxel—skin cancer	0.000507	0.0028	CcSEcCtD
Ranitidine—Alopecia—Fluorouracil—skin cancer	0.000505	0.00279	CcSEcCtD
Ranitidine—Diarrhoea—Imiquimod—skin cancer	0.000503	0.00278	CcSEcCtD
Ranitidine—Discomfort—Dactinomycin—skin cancer	0.000502	0.00278	CcSEcCtD
Ranitidine—Angina pectoris—Docetaxel—skin cancer	0.000502	0.00277	CcSEcCtD
Ranitidine—Ill-defined disorder—Temozolomide—skin cancer	0.000501	0.00277	CcSEcCtD
Ranitidine—Anaemia—Temozolomide—skin cancer	0.000499	0.00276	CcSEcCtD
Ranitidine—Erythema—Fluorouracil—skin cancer	0.000497	0.00275	CcSEcCtD
Ranitidine—Agitation—Temozolomide—skin cancer	0.000496	0.00274	CcSEcCtD
Ranitidine—Angioedema—Temozolomide—skin cancer	0.000493	0.00273	CcSEcCtD
Ranitidine—Pancytopenia—Docetaxel—skin cancer	0.000489	0.00271	CcSEcCtD
Ranitidine—Hypotension—Bleomycin—skin cancer	0.000488	0.0027	CcSEcCtD
Ranitidine—Malaise—Temozolomide—skin cancer	0.000487	0.00269	CcSEcCtD
Ranitidine—Dizziness—Imiquimod—skin cancer	0.000486	0.00269	CcSEcCtD
Ranitidine—Vertigo—Temozolomide—skin cancer	0.000485	0.00268	CcSEcCtD
Ranitidine—Leukopenia—Temozolomide—skin cancer	0.000483	0.00267	CcSEcCtD
Ranitidine—Neutropenia—Docetaxel—skin cancer	0.000482	0.00266	CcSEcCtD
Ranitidine—Thrombocytopenia—Dactinomycin—skin cancer	0.000477	0.00264	CcSEcCtD
Ranitidine—Musculoskeletal discomfort—Bleomycin—skin cancer	0.000476	0.00263	CcSEcCtD
Ranitidine—Vision blurred—Fluorouracil—skin cancer	0.000469	0.00259	CcSEcCtD
Ranitidine—Vomiting—Imiquimod—skin cancer	0.000467	0.00258	CcSEcCtD
Ranitidine—Weight decreased—Docetaxel—skin cancer	0.000466	0.00258	CcSEcCtD
Ranitidine—Dyspnoea—Bleomycin—skin cancer	0.000466	0.00257	CcSEcCtD
Ranitidine—Rash—Imiquimod—skin cancer	0.000464	0.00256	CcSEcCtD
Ranitidine—Dermatitis—Imiquimod—skin cancer	0.000463	0.00256	CcSEcCtD
Ranitidine—Pneumonia—Docetaxel—skin cancer	0.000462	0.00255	CcSEcCtD
Ranitidine—Headache—Imiquimod—skin cancer	0.000461	0.00255	CcSEcCtD
Ranitidine—Anaemia—Fluorouracil—skin cancer	0.00046	0.00254	CcSEcCtD
Ranitidine—Myalgia—Temozolomide—skin cancer	0.00046	0.00254	CcSEcCtD
Ranitidine—Arthralgia—Temozolomide—skin cancer	0.00046	0.00254	CcSEcCtD
Ranitidine—Discomfort—Temozolomide—skin cancer	0.000454	0.00251	CcSEcCtD
Ranitidine—Jaundice—Docetaxel—skin cancer	0.000448	0.00248	CcSEcCtD
Ranitidine—Pain—Bleomycin—skin cancer	0.000447	0.00247	CcSEcCtD
Ranitidine—Leukopenia—Fluorouracil—skin cancer	0.000445	0.00246	CcSEcCtD
Ranitidine—Confusional state—Temozolomide—skin cancer	0.000444	0.00246	CcSEcCtD
Ranitidine—Musculoskeletal discomfort—Dactinomycin—skin cancer	0.000444	0.00245	CcSEcCtD
Ranitidine—Anaphylactic shock—Temozolomide—skin cancer	0.000441	0.00244	CcSEcCtD
Ranitidine—Nausea—Imiquimod—skin cancer	0.000437	0.00241	CcSEcCtD
Ranitidine—Thrombocytopenia—Temozolomide—skin cancer	0.000431	0.00238	CcSEcCtD
Ranitidine—Feeling abnormal—Bleomycin—skin cancer	0.00043	0.00238	CcSEcCtD
Ranitidine—Agranulocytosis—Docetaxel—skin cancer	0.000429	0.00237	CcSEcCtD
Ranitidine—Hyperhidrosis—Temozolomide—skin cancer	0.000426	0.00235	CcSEcCtD
Ranitidine—Chest pain—Fluorouracil—skin cancer	0.000423	0.00234	CcSEcCtD
Ranitidine—Myalgia—Fluorouracil—skin cancer	0.000423	0.00234	CcSEcCtD
Ranitidine—Discomfort—Fluorouracil—skin cancer	0.000418	0.00231	CcSEcCtD
Ranitidine—Pain—Dactinomycin—skin cancer	0.000417	0.0023	CcSEcCtD
Ranitidine—Urticaria—Bleomycin—skin cancer	0.000415	0.00229	CcSEcCtD
Ranitidine—Body temperature increased—Bleomycin—skin cancer	0.000413	0.00228	CcSEcCtD
Ranitidine—Hepatitis—Docetaxel—skin cancer	0.000412	0.00228	CcSEcCtD
Ranitidine—Confusional state—Fluorouracil—skin cancer	0.000409	0.00226	CcSEcCtD
Ranitidine—Anaphylactic shock—Fluorouracil—skin cancer	0.000406	0.00224	CcSEcCtD
Ranitidine—Feeling abnormal—Dactinomycin—skin cancer	0.000401	0.00222	CcSEcCtD
Ranitidine—Musculoskeletal discomfort—Temozolomide—skin cancer	0.000401	0.00222	CcSEcCtD
Ranitidine—Insomnia—Temozolomide—skin cancer	0.000399	0.0022	CcSEcCtD
Ranitidine—Thrombocytopenia—Fluorouracil—skin cancer	0.000397	0.0022	CcSEcCtD
Ranitidine—Tachycardia—Fluorouracil—skin cancer	0.000396	0.00219	CcSEcCtD
Ranitidine—Dyspnoea—Temozolomide—skin cancer	0.000393	0.00217	CcSEcCtD
Ranitidine—Somnolence—Temozolomide—skin cancer	0.000392	0.00217	CcSEcCtD
Ranitidine—Erythema multiforme—Docetaxel—skin cancer	0.00039	0.00216	CcSEcCtD
Ranitidine—Abdominal pain—Dactinomycin—skin cancer	0.000385	0.00213	CcSEcCtD
Ranitidine—Body temperature increased—Dactinomycin—skin cancer	0.000385	0.00213	CcSEcCtD
Ranitidine—Hypersensitivity—Bleomycin—skin cancer	0.000385	0.00213	CcSEcCtD
Ranitidine—Hypotension—Fluorouracil—skin cancer	0.000379	0.0021	CcSEcCtD
Ranitidine—Constipation—Temozolomide—skin cancer	0.000377	0.00208	CcSEcCtD
Ranitidine—Pain—Temozolomide—skin cancer	0.000377	0.00208	CcSEcCtD
Ranitidine—Musculoskeletal discomfort—Fluorouracil—skin cancer	0.00037	0.00204	CcSEcCtD
Ranitidine—Pruritus—Bleomycin—skin cancer	0.00037	0.00204	CcSEcCtD
Ranitidine—Arrhythmia—Docetaxel—skin cancer	0.000368	0.00204	CcSEcCtD
Ranitidine—Insomnia—Fluorouracil—skin cancer	0.000367	0.00203	CcSEcCtD
Ranitidine—Alopecia—Docetaxel—skin cancer	0.000364	0.00201	CcSEcCtD
Ranitidine—Feeling abnormal—Temozolomide—skin cancer	0.000363	0.00201	CcSEcCtD
Ranitidine—Dyspnoea—Fluorouracil—skin cancer	0.000362	0.002	CcSEcCtD
Ranitidine—Somnolence—Fluorouracil—skin cancer	0.000361	0.002	CcSEcCtD
Ranitidine—Erythema—Docetaxel—skin cancer	0.000359	0.00198	CcSEcCtD
Ranitidine—Hypersensitivity—Dactinomycin—skin cancer	0.000359	0.00198	CcSEcCtD
Ranitidine—Urticaria—Temozolomide—skin cancer	0.00035	0.00193	CcSEcCtD
Ranitidine—Abdominal pain—Temozolomide—skin cancer	0.000348	0.00193	CcSEcCtD
Ranitidine—Body temperature increased—Temozolomide—skin cancer	0.000348	0.00193	CcSEcCtD
Ranitidine—Pain—Fluorouracil—skin cancer	0.000347	0.00192	CcSEcCtD
Ranitidine—Feeling abnormal—Fluorouracil—skin cancer	0.000335	0.00185	CcSEcCtD
Ranitidine—Diarrhoea—Dactinomycin—skin cancer	0.000333	0.00184	CcSEcCtD
Ranitidine—Vomiting—Bleomycin—skin cancer	0.000332	0.00184	CcSEcCtD
Ranitidine—Anaemia—Docetaxel—skin cancer	0.000332	0.00183	CcSEcCtD
Ranitidine—Rash—Bleomycin—skin cancer	0.000329	0.00182	CcSEcCtD
Ranitidine—Dermatitis—Bleomycin—skin cancer	0.000329	0.00182	CcSEcCtD
Ranitidine—Hypersensitivity—Temozolomide—skin cancer	0.000325	0.00179	CcSEcCtD
Ranitidine—Urticaria—Fluorouracil—skin cancer	0.000323	0.00178	CcSEcCtD
Ranitidine—Leukopenia—Docetaxel—skin cancer	0.000321	0.00178	CcSEcCtD
Ranitidine—Body temperature increased—Fluorouracil—skin cancer	0.000321	0.00177	CcSEcCtD
Ranitidine—Pruritus—Temozolomide—skin cancer	0.000312	0.00172	CcSEcCtD
Ranitidine—Nausea—Bleomycin—skin cancer	0.00031	0.00172	CcSEcCtD
Ranitidine—Vomiting—Dactinomycin—skin cancer	0.00031	0.00171	CcSEcCtD
Ranitidine—Rash—Dactinomycin—skin cancer	0.000307	0.0017	CcSEcCtD
Ranitidine—Chest pain—Docetaxel—skin cancer	0.000306	0.00169	CcSEcCtD
Ranitidine—Arthralgia—Docetaxel—skin cancer	0.000306	0.00169	CcSEcCtD
Ranitidine—Myalgia—Docetaxel—skin cancer	0.000306	0.00169	CcSEcCtD
Ranitidine—Diarrhoea—Temozolomide—skin cancer	0.000301	0.00167	CcSEcCtD
Ranitidine—Hypersensitivity—Fluorouracil—skin cancer	0.000299	0.00165	CcSEcCtD
Ranitidine—Confusional state—Docetaxel—skin cancer	0.000295	0.00163	CcSEcCtD
Ranitidine—Anaphylactic shock—Docetaxel—skin cancer	0.000293	0.00162	CcSEcCtD
Ranitidine—Dizziness—Temozolomide—skin cancer	0.000291	0.00161	CcSEcCtD
Ranitidine—Nausea—Dactinomycin—skin cancer	0.000289	0.0016	CcSEcCtD
Ranitidine—Pruritus—Fluorouracil—skin cancer	0.000287	0.00159	CcSEcCtD
Ranitidine—Thrombocytopenia—Docetaxel—skin cancer	0.000287	0.00159	CcSEcCtD
Ranitidine—Tachycardia—Docetaxel—skin cancer	0.000286	0.00158	CcSEcCtD
Ranitidine—Vomiting—Temozolomide—skin cancer	0.00028	0.00155	CcSEcCtD
Ranitidine—Rash—Temozolomide—skin cancer	0.000278	0.00154	CcSEcCtD
Ranitidine—Diarrhoea—Fluorouracil—skin cancer	0.000278	0.00154	CcSEcCtD
Ranitidine—Dermatitis—Temozolomide—skin cancer	0.000278	0.00153	CcSEcCtD
Ranitidine—Headache—Temozolomide—skin cancer	0.000276	0.00153	CcSEcCtD
Ranitidine—Hypotension—Docetaxel—skin cancer	0.000274	0.00151	CcSEcCtD
Ranitidine—Dizziness—Fluorouracil—skin cancer	0.000268	0.00148	CcSEcCtD
Ranitidine—Musculoskeletal discomfort—Docetaxel—skin cancer	0.000267	0.00148	CcSEcCtD
Ranitidine—Insomnia—Docetaxel—skin cancer	0.000265	0.00147	CcSEcCtD
Ranitidine—Nausea—Temozolomide—skin cancer	0.000262	0.00145	CcSEcCtD
Ranitidine—Dyspnoea—Docetaxel—skin cancer	0.000261	0.00144	CcSEcCtD
Ranitidine—Somnolence—Docetaxel—skin cancer	0.00026	0.00144	CcSEcCtD
Ranitidine—Vomiting—Fluorouracil—skin cancer	0.000258	0.00143	CcSEcCtD
Ranitidine—Rash—Fluorouracil—skin cancer	0.000256	0.00141	CcSEcCtD
Ranitidine—Dermatitis—Fluorouracil—skin cancer	0.000256	0.00141	CcSEcCtD
Ranitidine—Headache—Fluorouracil—skin cancer	0.000254	0.00141	CcSEcCtD
Ranitidine—Constipation—Docetaxel—skin cancer	0.000251	0.00139	CcSEcCtD
Ranitidine—Pain—Docetaxel—skin cancer	0.000251	0.00139	CcSEcCtD
Ranitidine—Feeling abnormal—Docetaxel—skin cancer	0.000241	0.00133	CcSEcCtD
Ranitidine—Nausea—Fluorouracil—skin cancer	0.000241	0.00133	CcSEcCtD
Ranitidine—Abdominal pain—Docetaxel—skin cancer	0.000232	0.00128	CcSEcCtD
Ranitidine—Body temperature increased—Docetaxel—skin cancer	0.000232	0.00128	CcSEcCtD
Ranitidine—Hypersensitivity—Docetaxel—skin cancer	0.000216	0.00119	CcSEcCtD
Ranitidine—Pruritus—Docetaxel—skin cancer	0.000207	0.00115	CcSEcCtD
Ranitidine—Diarrhoea—Docetaxel—skin cancer	0.0002	0.00111	CcSEcCtD
Ranitidine—Dizziness—Docetaxel—skin cancer	0.000194	0.00107	CcSEcCtD
Ranitidine—Vomiting—Docetaxel—skin cancer	0.000186	0.00103	CcSEcCtD
Ranitidine—Rash—Docetaxel—skin cancer	0.000185	0.00102	CcSEcCtD
Ranitidine—Dermatitis—Docetaxel—skin cancer	0.000185	0.00102	CcSEcCtD
Ranitidine—Headache—Docetaxel—skin cancer	0.000184	0.00101	CcSEcCtD
Ranitidine—Nausea—Docetaxel—skin cancer	0.000174	0.000962	CcSEcCtD
